Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05732623Recruiting

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

Role: lead

NCT06708429Recruiting

Lynch Syndrome X-Talk of Enteral Mucosa With Immune System

Role: lead

NCT05704010Not ApplicableRecruiting

Videocapsule Endoscopy in Lynch Syndrome

Role: lead

NCT07450612Recruiting

Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection

Role: lead

All 4 trials loaded